RU94036344A - Method for treating aids cases - Google Patents

Method for treating aids cases

Info

Publication number
RU94036344A
RU94036344A RU94036344/14A RU94036344A RU94036344A RU 94036344 A RU94036344 A RU 94036344A RU 94036344/14 A RU94036344/14 A RU 94036344/14A RU 94036344 A RU94036344 A RU 94036344A RU 94036344 A RU94036344 A RU 94036344A
Authority
RU
Russia
Prior art keywords
treating aids
aids cases
therapy
antiviral
polydan
Prior art date
Application number
RU94036344/14A
Other languages
Russian (ru)
Inventor
Е.И. Нестерова
Л.К. Пашук
А.В. Асафов
В.В. Безюлев
Original Assignee
Научно-производственное предприятие "Фармэк"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Научно-производственное предприятие "Фармэк" filed Critical Научно-производственное предприятие "Фармэк"
Priority to RU94036344/14A priority Critical patent/RU94036344A/en
Publication of RU94036344A publication Critical patent/RU94036344A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

FIELD: medicine. SUBSTANCE: method involves additionally administering Polydan preparation before starting antiviral protection therapy and later in prescribed mode. EFFECT: prevented toxic complications of antiviral therapy.

Claims (1)

Изобретение относится к медицине и биологии и касается способов лечения СПИДа. Сущность изобретения состоит в дополнительном введении препарата Полидан до начала курса АЗТ и после него в определенном режиме. Способ позволяет уменьшить токсические осложнения противовирусной терапии.The invention relates to medicine and biology and relates to methods for treating AIDS. The invention consists in the additional administration of the drug Polydan before the start of the AZT course and after it in a certain mode. The method allows to reduce the toxic complications of antiviral therapy.
RU94036344/14A 1994-09-29 1994-09-29 Method for treating aids cases RU94036344A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU94036344/14A RU94036344A (en) 1994-09-29 1994-09-29 Method for treating aids cases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU94036344/14A RU94036344A (en) 1994-09-29 1994-09-29 Method for treating aids cases

Publications (1)

Publication Number Publication Date
RU94036344A true RU94036344A (en) 1996-07-20

Family

ID=48449299

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94036344/14A RU94036344A (en) 1994-09-29 1994-09-29 Method for treating aids cases

Country Status (1)

Country Link
RU (1) RU94036344A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002080938A1 (en) * 2001-04-10 2002-10-17 Aleksandr Vilenovich Asafov Use of sodium nucleospermate for treating aids and treatment method

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002080938A1 (en) * 2001-04-10 2002-10-17 Aleksandr Vilenovich Asafov Use of sodium nucleospermate for treating aids and treatment method

Similar Documents

Publication Publication Date Title
FI945621A (en) Controlled solvents
EP0962225A3 (en) Use of phentolamine for the manufacture of a medicament for the treatment of erectile dysfunction
ATE170077T1 (en) METHOD FOR TREATING CANCER BY COMBINATION THERAPY WITH 2'-HALOMETHYLIDE DERIVATIVES AND AN S-OR M-PHASE-SPECIFIC ANTINEOPLASTIC ACTIVE INGREDIENT
HUT60630A (en) Process or producing peroral pharmaceutical compositions suitable for treating internal diseases of inflammatory nature
PT668763E (en) USE OF FENSERIN FOR THE PREPARATION OF MEDICINES TO TREAT DISEASES OF KNOWLEDGE
RU95101385A (en) Products containing g-csf and tnf-binding protein
UA32457C2 (en) Drug (variants) and methods for exposure to drug
HUP0100012A2 (en) Use for macrolides for the treatment of cancer and macular degeneration
WO1999033450A3 (en) Pharmaceutical composition containing sibutramine and orlistat
HU907959D0 (en) Medical preparations
RU94036344A (en) Method for treating aids cases
BR9406865A (en) Use of a pharmaceutically acceptable salt of ropivacaine in the manufacture of a pharmaceutical process for the treatment of a person in need of pain relief and pharmaceutical preparation
WO2000016786A3 (en) Oxihumic acid and its use in the treatment of various conditions
WO1997026880A3 (en) Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients
RU95105249A (en) Ng monomethyl-l-arginine hydrochloride, processes for preparation thereof, process for preparation of pharmaceutical agent, and method of treatment
DE69733321D1 (en) OLANZAPINE FOR THE TREATMENT OF DRUG ABUSE
ATE308995T1 (en) PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING RETROVIRAL INFECTIONS
WO1999013894A3 (en) Use of ifn-alpha and amantadine for the treatment of chronic hepatitis c
MD1469G2 (en) Method of treatment of the burn shock
RU94037731A (en) Method for treating multiple sclerosis
RU94036169A (en) Method for treating hepatitis
RU94000695A (en) Agent showing antiallergic action
RU94033867A (en) Method for stimulating apud system
RU94022334A (en) Method of treatment and prophylaxis of invasion diseases
RU95106139A (en) Method of lung tuberculosis treatment